Updated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Applying Guideline Recommendations to ACS Management
Steve Jackson, PharmD
Sunil Rao, MD
The Role of TTR Stabilization in ATTR-CM Treatment
Sumeet Mitter MD, MSc, FACC
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Mary Leuchars, MD
Mark Creager, MD
Risk Prediction with the PREVENT-ASCVD Equations
Roger Blumenthal, MD
Managing Dyslipidemia: 2026 ACC/AHA Guideline Updates
From Goals to Action: Multisociety Guidance on Lipid Management
Ann Marie Navar, MD, PhD
Moving Toward Precision Medicine in PAH
Stephen Y. Chan, MD, PhD, FAHA
What’s Next for Pulmonary Arterial Hypertension Care?
Enlicitide for LDL-C Management: Insights from CORALreef Lipids
How PCSK9 Inhibition Lowers LDL Cholesterol
The Long Road to an FCS Diagnosis
Charles Turck, PharmD, BCPS, BCCCP
Peter P. Toth, MD, PhD, FAAFP, FICA, FAHA, FNLA, FCCP, FACC
Could It Be FCS? Recognizing the Diagnostic Clues
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Zahid Ahmad, MD, FNLA
Evaluating ASCVD Risk with the CPR Framework
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.